thimerosal has been researched along with Complications, Infectious Pregnancy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ault, KA; del Rio, C; Halsey, NA; Omer, SB; Steinhoff, MC; Tamma, PD | 1 |
Biroscak, BJ; Collins, MP; Fasano, N; Fineis, P; Fiore, AE; Stoltman, G | 1 |
Cieslak, PR; Corwith, HL; Fiore, AE; Margolis, HS; Thomas, AR | 1 |
1 review(s) available for thimerosal and Complications, Infectious Pregnancy
Article | Year |
---|---|
Safety of influenza vaccination during pregnancy.
Topics: Female; Humans; Infant, Newborn; Influenza Vaccines; Influenza, Human; Pregnancy; Pregnancy Complications, Infectious; Preservatives, Pharmaceutical; Safety; Thimerosal; Treatment Outcome | 2009 |
2 other study(ies) available for thimerosal and Complications, Infectious Pregnancy
Article | Year |
---|---|
Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.
Topics: Contraindications; Female; Health Planning Guidelines; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hospitals, Urban; Humans; Immunization Programs; Infant; Infant, Newborn; Infant, Newborn, Diseases; Mass Screening; Michigan; Pregnancy; Pregnancy Complications, Infectious; Preservatives, Pharmaceutical; Thimerosal | 2003 |
Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: effects of the Joint Statement on Thimerosal in Vaccines.
Topics: Cohort Studies; Confidence Intervals; Consumer Product Safety; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Immunity; Immunization Schedule; Infant, Newborn; Male; Mass Screening; Oregon; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Preservatives, Pharmaceutical; Probability; Risk Assessment; Sensitivity and Specificity; Thimerosal; Vaccination | 2004 |